Cargando…
Induced pluripotent stem cells in hematology: current and future applications
Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell tec...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042300/ https://www.ncbi.nlm.nih.gov/pubmed/24813079 http://dx.doi.org/10.1038/bcj.2014.30 |
_version_ | 1782318790725337088 |
---|---|
author | Focosi, D Amabile, G Di Ruscio, A Quaranta, P Tenen, D G Pistello, M |
author_facet | Focosi, D Amabile, G Di Ruscio, A Quaranta, P Tenen, D G Pistello, M |
author_sort | Focosi, D |
collection | PubMed |
description | Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation. |
format | Online Article Text |
id | pubmed-4042300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40423002014-06-12 Induced pluripotent stem cells in hematology: current and future applications Focosi, D Amabile, G Di Ruscio, A Quaranta, P Tenen, D G Pistello, M Blood Cancer J Review Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation. Nature Publishing Group 2014-05 2014-05-09 /pmc/articles/PMC4042300/ /pubmed/24813079 http://dx.doi.org/10.1038/bcj.2014.30 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Review Focosi, D Amabile, G Di Ruscio, A Quaranta, P Tenen, D G Pistello, M Induced pluripotent stem cells in hematology: current and future applications |
title | Induced pluripotent stem cells in hematology: current and future applications |
title_full | Induced pluripotent stem cells in hematology: current and future applications |
title_fullStr | Induced pluripotent stem cells in hematology: current and future applications |
title_full_unstemmed | Induced pluripotent stem cells in hematology: current and future applications |
title_short | Induced pluripotent stem cells in hematology: current and future applications |
title_sort | induced pluripotent stem cells in hematology: current and future applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042300/ https://www.ncbi.nlm.nih.gov/pubmed/24813079 http://dx.doi.org/10.1038/bcj.2014.30 |
work_keys_str_mv | AT focosid inducedpluripotentstemcellsinhematologycurrentandfutureapplications AT amabileg inducedpluripotentstemcellsinhematologycurrentandfutureapplications AT diruscioa inducedpluripotentstemcellsinhematologycurrentandfutureapplications AT quarantap inducedpluripotentstemcellsinhematologycurrentandfutureapplications AT tenendg inducedpluripotentstemcellsinhematologycurrentandfutureapplications AT pistellom inducedpluripotentstemcellsinhematologycurrentandfutureapplications |